InvestorsHub Logo

Chuckles759

05/31/20 1:00 PM

#81558 RE: weasel6667 #81555

So many stories of blatant bias....

A good one for "follow the money"...
A Tale of Two Drugs: Money vs. Medical Wisdom

Gilead's remdesivir can hardly live up to the hype

What the public didn’t hear about the NIH remdesivir trial

...you might see where my concern is shared with others about bias and preference at the cost of saving lives....